https://achieverx.com/news/ 2026-10-28T19:53:19+00:00 https://achieverx.com/oncogenex-pharmaceuticals-inc-and-achieve-life-science-inc-announce-definitive-merger-agreement/ 2017-01-05T23:09:43+00:00 https://achieverx.com/achieve-life-science-and-oncogenex-pharmaceuticals-announce-strategic-collaboration-with-the-national-institutes-of-health-to-advance-the-development-of-cytisine-for-smoking-cessation/ 2017-03-01T23:01:18+00:00 https://achieverx.com/achieve-life-sciences-and-oncogenex-pharmaceuticals-announce-cytisine-symposium-at-the-annual-society-for-research-in-nicotine-and-tobacco-conference-srnt/ 2017-03-08T17:38:26+00:00 https://achieverx.com/achieve-life-sciences-and-oncogenex-pharmaceuticals-announce-form-s-4-registration-statement-declared-effective-by-sec/ 2017-06-13T21:34:04+00:00 https://achieverx.com/achieve-life-sciences-annouces-closing-of-merger-with-oncogenex-pharmaceuticals/ 2017-08-01T19:51:49+00:00 https://achieverx.com/achieve-announces-fda-acceptance-of-ind-for-cytisine/ 2017-08-11T15:35:24+00:00 https://achieverx.com/achieve-announces-initiation-of-cytisine-clinical-development-program/ 2017-08-16T10:00:51+00:00 https://achieverx.com/achieve-announces-share-purchase-agreement-with-lincoln-park/ 2017-09-14T20:24:31+00:00 https://achieverx.com/achieve-announces-advancement-of-cytisine-clinical-development-program/ 2017-10-04T09:35:35+00:00 https://achieverx.com/achieve-announces-long-term-manufacturing-agreement-with-sopharma/ 2017-10-26T09:35:20+00:00 https://achieverx.com/achieve-announces-company-presentation-at-virtual-investor-conference/ 2017-10-30T12:00:36+00:00 https://achieverx.com/achieve-announces-availability-of-company-presentation-from-virtual-investor-conference/ 2017-11-06T12:00:33+00:00 https://achieverx.com/achieve-to-present-at-piper-jaffray/ 2017-11-08T15:13:32+00:00 https://achieverx.com/achieve-announces-results-of-fed-fasted-clinical-study/ 2017-11-14T09:30:00+00:00 https://achieverx.com/achieve-announces-clinical-trial-supply-cooperation-agreement/ 2017-11-28T10:30:38+00:00 https://achieverx.com/achieve-announces-expansion-of-bristol-partnership/ 2018-01-24T17:52:17+00:00 https://achieverx.com/achieve-announces-preliminary-data-from-ph1-2-cytisine-pk-pd-study/ 2018-02-20T13:04:39+00:00 https://achieverx.com/achieve-announces-recent-highlights-and-reports-ye2017-financial-results/ 2018-03-01T21:31:41+00:00 https://achieverx.com/achieve-announces-cytisine-symposium/ 2018-03-06T10:15:26+00:00 https://achieverx.com/achieve-announces-patent-novel-formulation-cytisine/ 2018-05-07T09:32:10+00:00 https://achieverx.com/achieve-announces-financial-results-1q-2018/ 2018-05-09T20:25:49+00:00 https://achieverx.com/achieve-announces-reverse-stock-split/ 2018-05-23T10:30:18+00:00 https://achieverx.com/achieve-announces-publication-of-data-for-next-generation-cytisine-molecules/ 2018-06-11T10:30:33+00:00 https://achieverx.com/achieve-announces-pricing-of-12million-underwritten-public-offering/ 2018-06-15T13:30:55+00:00 https://achieverx.com/achieve-announces-closing-of-public-offering/ 2018-06-19T21:02:23+00:00 https://achieverx.com/achieve-announces-positive-cytisine-data-demonstrating-no-significant-drug-drug-interaction/ 2018-06-26T10:30:11+00:00 https://achieverx.com/achieve-announces-advancement-of-cytisine-development-following-fda-meeting/ 2018-07-11T10:30:46+00:00 https://achieverx.com/achieve-to-release-q2-2018-financial-results-august-8/ 2018-08-02T10:30:00+00:00 https://achieverx.com/achieve-announces-financial-results-2q-2018/ 2018-08-08T21:05:26+00:00 https://achieverx.com/achieve-to-present-at-hcw-sept2018/ 2018-09-05T10:30:19+00:00 https://achieverx.com/achieve-announces-data-presented-at-srnt-e/ 2018-09-06T10:30:09+00:00 https://achieverx.com/achieve-announces-positive-cytisine-data-published-in-international-journal-of-drug-policy/ 2018-09-18T10:30:31+00:00 https://achieverx.com/achieve-to-present-at-ladenburg-thalmann-2018/ 2018-09-26T10:30:47+00:00 https://achieverx.com/achieve-announces-results-of-clinical-study-demonstrating-similar-bioavailability/ 2018-09-27T10:30:54+00:00 https://achieverx.com/achieve-announces-pricing-of-5-6million-registered-direct-offering/ 2018-10-01T13:50:52+00:00 https://achieverx.com/achieve-announces-initiation-phase2b-orca-1-trial/ 2018-10-30T10:30:40+00:00 https://achieverx.com/achieve-to-announce-q3-2018-financial-results/ 2018-10-31T10:30:42+00:00 https://achieverx.com/achieve-announces-financial-results-3q-2018/ 2018-11-07T09:00:50+00:00 https://achieverx.com/achieve-announces-update-on-cyticinicline-clin-dev-prog/ 2018-12-18T10:30:51+00:00 https://achieverx.com/achieve-announces-completion-of-enrollment-ph2b-trial/ 2019-02-20T10:30:16+00:00 https://achieverx.com/achieve-announces-ph1-2-multidose-pk-pd-study-presented-at-srnt/ 2019-02-22T10:30:23+00:00 https://achieverx.com/achieve-to-announce-ye2018-financial-results/ 2019-03-05T10:30:21+00:00 https://achieverx.com/achieve-announces-financial-results-ye-2018/ 2019-03-14T21:00:09+00:00 https://achieverx.com/achieve-to-present-at-oppenheimer-mar20/ 2019-03-18T10:30:49+00:00 https://achieverx.com/achieve-announces-final-dsmc-reveiw-orca1/ 2019-04-02T10:35:12+00:00 https://achieverx.com/achieve-to-present-at-hcw-april2019/ 2019-04-03T10:35:45+00:00 https://achieverx.com/achieve-announces-last-visit-completed-ph2b-orca1-trial/ 2019-04-24T10:30:59+00:00 https://achieverx.com/achieve-to-announce-q1-2019-financial-results/ 2019-05-07T10:30:52+00:00 https://achieverx.com/achieve-announces-financial-results-q1-2019/ 2019-05-15T20:05:44+00:00 https://achieverx.com/achieve-announces-patent-granted/ 2019-05-30T10:30:03+00:00 https://achieverx.com/achieve-receives-4-2m-from-warrants/ 2019-06-03T20:05:15+00:00 https://achieverx.com/achieve-announces-ph2b-orca1-results/ 2019-06-11T12:05:36+00:00 https://achieverx.com/achieve-announces-ph2b-orca1-data-presentation-srnt-e/ 2019-06-21T10:30:19+00:00 https://achieverx.com/achieve-extends-nih-collaboration/ 2019-07-23T10:30:22+00:00 https://achieverx.com/achieve-to-announce-q2-2019-financial-results/ 2019-07-30T10:30:14+00:00 https://achieverx.com/achieve-announces-financial-results-q2-2019-2/ 2019-08-08T20:05:37+00:00 https://achieverx.com/achieve-to-present-upcoming-conferences/ 2019-09-04T10:30:39+00:00 https://achieverx.com/achieve-investor-day-sept-20/ 2019-09-05T10:30:55+00:00 https://achieverx.com/achieve-announces-srnt-e-orca-1-presentation/ 2019-09-13T10:30:06+00:00 https://achieverx.com/achieve-announces-mtd-study-completion/ 2019-09-30T10:30:37+00:00 https://achieverx.com/achieve-announces-srnt-o-presentation/ 2019-10-24T10:30:31+00:00 https://achieverx.com/achieve-to-announce-3q19-financial-results/ 2019-10-31T10:30:12+00:00 https://achieverx.com/achieve-to-announce-q3-2019-financial-results/ 2019-11-06T11:30:21+00:00 https://achieverx.com/achieve-announces-update-following-fda-meeting/ 2019-12-09T10:35:23+00:00 https://achieverx.com/achieve-announces-12million-underwritten-public-offering/ 2019-12-17T18:12:17+00:00 https://achieverx.com/achieve-announces-closing-of-underwritten-public-offering-2/ 2019-12-19T21:05:17+00:00 https://achieverx.com/achieve-university-of-bristol-oracle-announce-study-results-demonstrating-potential-for-accelerated-speed-of-drug-discovery/ 2020-01-13T17:16:38+00:00 https://achieverx.com/achieve-announces-agreement-with-freemind-group-to-assist-in-securing-non-dilutive-funding-to-evaluate-cytisinicline-in-vaping/ 2020-02-06T13:00:05+00:00 https://achieverx.com/achieve-to-announce-4th-quarter-and-year-end-2019-financial-results/ 2020-03-03T10:30:02+00:00 https://achieverx.com/achieve-announces-presentation-of-additional-cytisinicline-analyses-at-srnt-annual-meeting/ 2020-03-12T10:30:30+00:00 https://achieverx.com/achieve-reports-financial-results-for-4th-quarter-and-year-end-2019/ 2020-03-13T10:00:15+00:00 https://achieverx.com/achieve-announces-private-placement-of-1-9-million/ 2020-04-30T20:51:08+00:00 https://achieverx.com/achieve-to-announce-q1-2020-financial-results/ 2020-05-05T13:00:44+00:00 https://achieverx.com/achieve-reports-financial-results-for-1st-quarter-2020/ 2020-05-14T12:30:22+00:00 https://achieverx.com/achieve-announces-successful-results-from-investigator-initiated-rauora-trial/ 2020-06-29T08:30:38+00:00 https://achieverx.com/achieve-announces-pricing-of-6m-registered-direct-offering/ 2020-06-29T08:35:33+00:00 https://achieverx.com/achieve-to-announce-2q20-financial-results/ 2020-07-28T09:30:52+00:00 https://achieverx.com/achieve-announces-us-patent-novel-analogs-of-cytisinicline-in-cns-and-addiction-indications/ 2020-07-31T12:30:52+00:00 https://achieverx.com/achieve-announces-proposed-public-offering/ 2020-08-03T20:00:05+00:00 https://achieverx.com/achieve-announces-pricing-of-6-5m-public-offering/ 2020-08-04T13:00:50+00:00 https://achieverx.com/achieve-reports-financial-results-for-2nd-quarter-2020-2/ 2020-08-06T20:05:23+00:00 https://achieverx.com/achieve-to-present-at-upcoming-investor-conferences/ 2020-09-03T09:30:54+00:00 https://achieverx.com/achieve-announces-presentation-of-cytisinicline-data-at-srnt-e-virtual-conference/ 2020-09-10T09:30:02+00:00 https://achieverx.com/achieve-announces-results-from-evaluation-of-cytisinicline-vs-chantix/ 2020-09-18T11:00:14+00:00 https://achieverx.com/achieve-announces-presentation-of-investigator-led-rauora-trial/ 2020-09-18T12:45:38+00:00 https://achieverx.com/achieve-announces-appointment-of-john-bencich-to-ceo-and-dr-cindy-jacobs-to-president/ 2020-09-30T12:00:57+00:00 https://achieverx.com/achieve-announces-start-of-phase3-orca2-clinical-trial-evaluating-cytisinicline-for-smoking-cessation/ 2020-10-07T10:30:05+00:00 https://achieverx.com/achieve-to-present-at-microcap-best-ideas-conference/ 2020-10-08T10:30:53+00:00 https://achieverx.com/achv-sh-ltr-oct-20/ 2020-10-22T13:00:18+00:00 https://achieverx.com/achieve-to-host-smoking-cessation-kol-roundtable/ 2020-10-27T09:30:14+00:00 https://achieverx.com/achieve-to-announce-3q20-financial-results/ 2020-10-29T09:30:51+00:00 https://achieverx.com/achieve-reports-financial-results-for-3rd-quarter-2020/ 2020-11-12T20:05:10+00:00 https://achieverx.com/achieve-announces-proposed-public-offering-2/ 2020-11-30T16:14:36+00:00 https://achieverx.com/achieve-announces-pricing-of-15m-public-offering/ 2020-12-03T12:00:02+00:00 https://achieverx.com/achieve-announces-closing-17-3m-underwritten-public-offering/ 2020-12-07T20:05:20+00:00 https://achieverx.com/achieve-to-present-at-hcwainwright-bioconnect/ 2021-01-07T09:30:37+00:00 https://achieverx.com/achieve-to-present-at-microcap-rodeo-winter-conference/ 2021-02-11T13:00:32+00:00 https://achieverx.com/achieve-announces-srnt2021-presentation/ 2021-02-24T11:30:51+00:00 https://achieverx.com/achieve-to-announce-fourth-quarter-and-year-end-2020-financial-results-and-host-conference-call-and-webcast-on-march-11-2021/ 2021-03-04T10:30:03+00:00 https://achieverx.com/achieve-reports-financial-results-for-4th-quarter-and-year-end-2020-and-provides-corporate-update/ 2021-03-11T21:05:08+00:00 https://achieverx.com/achieve-announces-appointment-of-dr-bridget-martell-and-dr-cindy-jacobs-to-board-of-directors/ 2021-03-15T11:30:46+00:00 https://achieverx.com/achieve-to-participate-in-m-vest-and-maxim-group-inagural-emerging-growth-virtual-conference/ 2021-03-16T10:30:57+00:00 https://achieverx.com/achieve-announces-publication-of-the-rauora-head-to-head-non-inferiority-clinical-trial-comparing-cytisinicline-and-chantix/ 2021-03-25T09:30:56+00:00 https://achieverx.com/achieve-announces-publication-of-orca1-phase2b-clinical-trial-of-cytisinicline-in-adult-smokers-in-nicotine-and-tobacco-research/ 2021-04-14T09:30:55+00:00 https://achieverx.com/achieve-to-host-virtual-non-deal-roadshow-april-27-2021/ 2021-04-22T09:30:48+00:00 https://achieverx.com/achieve-to-announce-first-quarter-2021-financial-results-may-13-2021/ 2021-05-04T09:30:54+00:00 https://achieverx.com/achieve-reports-financial-results-for-first-quarter-2021/ 2021-05-13T20:05:27+00:00 https://achieverx.com/achieve-announces-proposed-underwritten-public-offering/ 2021-05-24T20:05:17+00:00 https://achieverx.com/achieve-announces-pricing-of-20m-underwritten-public-offering/ 2021-05-25T12:30:51+00:00 https://achieverx.com/achieve-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/ 2021-05-27T20:05:06+00:00 https://achieverx.com/achieve-to-present-at-ld-micro-invitational-virtual-conference/ 2021-06-02T09:30:39+00:00 https://achieverx.com/achieve-announces-allowance-of-us-patents-for-dosing-and-administration-of-cytisinicline-for-the-treatment-and-prevention-of-addiction/ 2021-06-03T09:30:05+00:00 https://achieverx.com/achieve-announces-completion-of-target-enrollment-of-750-subjects-in-phase-3-orca-2-smoking-cessation-trial-of-cytisinicline/ 2021-06-29T09:30:18+00:00 https://achieverx.com/achieve-awarded-nih-grant-for-evaluation-of-cytisinicline-in-cessation-of-nicotine-e-cigarette-use/ 2021-07-22T09:30:32+00:00 https://achieverx.com/achieve-to-announce-q2-2021-financial-results-august-12/ 2021-08-03T09:30:25+00:00 https://achieverx.com/achieve-announces-two-patents-granted-by-uspto-for-novel-cytisinicline-dosing-and-administration-regimen/ 2021-08-11T09:30:59+00:00 https://achieverx.com/achieve-reports-financial-results-for-second-quarter-2021-and-provides-corporate-update/ 2021-08-12T12:30:16+00:00 https://achieverx.com/achieve-announces-expansion-of-cytisinicline-clinical-operations-team/ 2021-08-13T09:30:56+00:00 https://achieverx.com/achieve-to-participate-in-two-upcoming-investor-conferences/ 2021-09-09T09:30:24+00:00 https://achieverx.com/achieve-announces-presentation-of-cytisinicline-data-at-srnt-e-virtual-conference-2/ 2021-09-14T09:30:27+00:00 https://achieverx.com/achieve-to-participate-in-upcoming-investor-conferences/ 2021-09-15T09:30:15+00:00 https://achieverx.com/achieve-to-announce-third-quarter-2021-financial-results/ 2021-10-26T12:30:20+00:00 https://achieverx.com/achieve-announces-fda-acceptance-of-ind-application-for-nicotine-e-cigarette-cessation/ 2021-11-02T12:30:25+00:00 https://achieverx.com/achieve-announces-participation-in-november-investor-conferences/ 2021-11-04T12:30:41+00:00 https://achieverx.com/achieve-reports-financial-results-for-third-quarter-2021-and-provides-update-on-cytisinicline-development/ 2021-11-09T21:05:49+00:00 https://achieverx.com/achieve-announces-phase-3-orca-2-trial-clears-final-data-safety-monitoring-committee-review/ 2021-11-22T13:30:10+00:00 https://achieverx.com/achieve-to-host-key-opinion-leader-panel-on-smoking-and-e-cigarette-cessation/ 2021-11-23T13:30:06+00:00 https://achieverx.com/achieve-announces-25-million-loan-facility-from-silicon-valley-bank-to-fund-cytisinicline-smoking-cessation-clinical-development/ 2021-12-22T13:30:13+00:00 https://achieverx.com/achieve-announces-completion-of-last-subject-last-visit-in-phase-3-orca-2-trial-of-cytisinicline-for-smoking-cessation/ 2022-01-04T13:30:58+00:00 https://achieverx.com/achieve-to-present-at-hc-wainwright-bioconnect-virtual-conference/ 2022-01-06T13:30:17+00:00 https://achieverx.com/achieve-announces-initiation-of-phase-3-orca-3-trial-evaluating-cytisinicline-for-smoking-cessation/ 2022-01-25T13:00:58+00:00 https://achieverx.com/achieve-announces-participation-in-february-investor-conferences/ 2022-02-02T13:00:13+00:00 https://achieverx.com/achieve-to-announce-fourth-quarter-and-year-end-2021-financial-results/ 2022-02-24T13:00:22+00:00 https://achieverx.com/achieve-announces-participation-in-march-investor-conferences/ 2022-03-08T13:00:33+00:00 https://achieverx.com/achieve-reports-financial-results-for-fourth-quarter-and-year-end-2021-and-provides-corporate-update/ 2022-03-10T13:00:39+00:00 https://achieverx.com/achieve-announces-expansion-of-manufacturing-and-quality-operations-team-and-inducement-grant-award/ 2022-03-11T13:00:21+00:00 https://achieverx.com/achieve-announces-presentation-at-srnt-annual-meeting/ 2022-03-15T12:00:38+00:00 https://achieverx.com/achieve-to-announce-1q22-earnings-may-12-2022/ 2022-04-21T12:02:27+00:00 https://achieverx.com/achieve-announces-successful-phase-3-orca-2-results/ 2022-04-27T16:33:55+00:00 https://achieverx.com/achieve-announces-participation-at-best-ideas-investor-conference/ 2022-05-13T12:00:00+00:00 https://achieverx.com/achieve-reports-1q22-financial-results/ 2022-05-12T20:00:00+00:00 https://achieverx.com/wp-content/uploads/2022/05/1q22.png https://achieverx.com/achieve-announces-participation-at-ld-micro-invitational-conference/ 2022-05-26T12:00:00+00:00 https://achieverx.com/achieve-awarded-nih-grant/ 2022-06-01T12:00:00+00:00 https://achieverx.com/achieve-announces-participation-at-hc-wainwright-1st-annual-mental-health-conference/ 2022-06-21T12:00:00+00:00 https://achieverx.com/achieve-announces-granting-of-new-hire-inducement-awards/ 2022-07-01T20:05:00+00:00 https://achieverx.com/achieve-initiates-phase-2-orca-v1-trial/ 2022-06-29T12:00:00+00:00 https://achieverx.com/achieve-to-announce-second-quarter-financial-results-august-11/ 2022-07-28T12:00:00+00:00 https://achieverx.com/achieve-reports-2q22-financial-results/ 2022-08-11T20:05:00+00:00 https://achieverx.com/wp-content/uploads/2022/08/Q2-22-Earnings.jpg https://achieverx.com/achieve-announces-participation-at-fall-investor-conferences/ 2022-09-07T12:00:00+00:00 https://achieverx.com/achieve-announces-completion-of-target-enrollment-in-phase-3-orca-3-trial/ 2022-09-27T12:00:00+00:00 https://achieverx.com/achieve-to-announce-3q22-financial-results/ 2022-10-31T12:00:00+00:00 https://achieverx.com/achieve-completes-target-enrollment-in-e-cigarette-cessation-trial/ 2022-11-08T13:00:00+00:00 https://achieverx.com/achieve-reports-3q22-financial-results-and-corporate-update/ 2022-11-14T21:07:43+00:00 https://achieverx.com/wp-content/uploads/2022/11/3q22_earnings.jpg https://achieverx.com/achieve-announces-private-placement-of-18-9m/ 2022-11-15T13:00:00+00:00 https://achieverx.com/achieve-announces-new-cytisinicline-formulation-patent/ 2022-12-21T13:00:00+00:00 https://achieverx.com/achieve-announces-last-subject-dosed-in-phase3-orca3-trial/ 2023-01-09T13:00:00+00:00 https://achieverx.com/achieve-announces-new-hire-inducement-awards/ 2023-01-27T21:30:00+00:00 https://achieverx.com/2023-svb-securities-global-biopharma-conference/ 2023-02-02T13:00:00+00:00 https://achieverx.com/achieve-announces-orca-v1-last-subject-dosed/ 2023-02-07T13:00:00+00:00 https://achieverx.com/achieve-to-announce-4q-ye-2022-financial-results/ 2023-03-02T13:00:00+00:00 https://achieverx.com/achieve-announces-presentation-of-phase3-orca2-trial-at-srnt/ 2023-03-03T13:00:00+00:00 https://achieverx.com/achieve-announces-last-subject-visit-in-phase-2-orca-v1-trial/ 2023-03-08T13:00:00+00:00 https://achieverx.com/achieve-announces-new-hire-inducement-award/ 2023-03-17T12:00:00+00:00 https://achieverx.com/achieve-reports-4q-and-year-end-2022-financial-results/ 2023-03-16T20:05:00+00:00 https://achieverx.com/wp-content/uploads/2023/03/Q4YE2022.jpg https://achieverx.com/achieve-announces-phase-3-orca-3-last-subject-visit-completed/ 2023-03-29T12:00:00+00:00 https://achieverx.com/achieve-announces-refresh-to-board-of-directors/ 2023-03-30T12:00:00+00:00 https://achieverx.com/achieve-to-present-at-life-science-innovation-northwest/ 2023-04-14T12:00:00+00:00 https://achieverx.com/achieve-announces-positive-phase-2-orca-v1-trial-results/ 2023-04-20T12:00:00+00:00 https://achieverx.com/achieve-to-announce-1q23-financial-results/ 2023-04-26T12:00:00+00:00 https://achieverx.com/achieve-reports-1q23-financial-results/ 2023-05-09T20:05:00+00:00 https://achieverx.com/wp-content/uploads/2023/05/achv-1q23-earnings.jpg https://achieverx.com/achieve-announces-refinancing-of-svb-loan/ 2023-05-17T12:00:00+00:00 https://achieverx.com/achieve-reports-statistically-significant-confirmatory-phase-3-results/ 2023-05-23T10:00:00+00:00 https://achieverx.com/achieve-announces-pricing-of-registered-direct-offering/ 2023-05-25T13:00:00+00:00 https://achieverx.com/achieve-announces-participation-at-upcoming-investor-conferences/ 2023-06-06T12:00:00+00:00 https://achieverx.com/achieve-announces-jama-phase-3-orca-2-trial-publication/ 2023-07-11T15:24:27+00:00 https://achieverx.com/achieve-announces-2023-american-society-of-pharmacognosy-presentation/ 2023-07-18T12:00:00+00:00 https://achieverx.com/achieve-to-announce-2q23-financial-results/ 2023-08-01T12:00:00+00:00 https://achieverx.com/achieve-announces-participation-at-upcoming-investor-conferences-2/ 2023-09-07T12:00:00+00:00 https://achieverx.com/achieve-announces-presentation-of-e-cigarette-cessation-results-at-srnt-e/ 2023-09-11T12:00:00+00:00 https://achieverx.com/achieve-announces-oct2023-investor-conference-participation/ 2023-10-03T12:00:00+00:00 https://achieverx.com/achieve-to-announce-3q23-financial-results/ 2023-10-26T12:00:00+00:00 https://achieverx.com/achieve-reports-3q23-financial-results/ 2023-11-09T21:00:00+00:00 https://achieverx.com/wp-content/uploads/2023/11/achv-3q23.jpg https://achieverx.com/achieve-announces-upcoming-investor-conference-participation/ 2023-12-11T21:31:19+00:00 https://achieverx.com/achieve-reaches-agreement-with-fda-on-long-term-cytisinicline-exposure-data-requirements-for-nda/ 2024-02-29T13:01:00+00:00 https://achieverx.com/achieve-announces-pricing-of-up-to-124-2m-registered-direct-offering-and-concurrent-private-placement/ 2024-02-29T13:00:00+00:00 https://achieverx.com/achieve-to-participate-in-march-2024-investor-conferences/ 2024-03-06T13:00:00+00:00 https://achieverx.com/achieve-to-announce-4q-and-2023-financial-results/ 2024-03-14T12:00:00+00:00 https://achieverx.com/achieve-announces-srnt2024-cytisinicline-orca-data-presentation/ 2024-03-20T12:00:00+00:00 https://achieverx.com/achieve-reports-ye2023-financial-results/ 2024-03-28T20:00:00+00:00 https://achieverx.com/wp-content/uploads/2024/03/achv-ye2023.jpg https://achieverx.com/achieve-to-present-at-lsinw2024/ 2024-04-11T12:00:00+00:00 https://achieverx.com/achieve-to-announce-1q24-financial-results/ 2024-04-25T12:00:00+00:00 https://achieverx.com/achieve-announces-publication-of-cytisinicline-vaping-cessation-trial-results-in-jama/ 2024-05-06T15:16:40+00:00 https://achieverx.com/achieve-reports-1q24-financial-results/ 2024-05-09T20:01:00+00:00 https://achieverx.com/wp-content/uploads/2024/05/achv-1q24.jpg https://achieverx.com/achieve-announces-orca-v1-data-presentation-at-sgim-annual-meeting/ 2024-05-17T12:00:00+00:00 https://achieverx.com/achieve-announces-initiation-of-orca-ol-trial/ 2024-05-29T12:00:00+00:00 https://achieverx.com/achieve-to-announce-2q24-financial-results/ 2024-07-25T12:00:00+00:00 https://achieverx.com/achieve-to-present-at-joneshealthcare-seaside-summit-2024/ 2024-07-09T12:00:00+00:00 https://achieverx.com/achieve-announces-addition-to-russell3000-and-microcap-indexes/ 2024-07-01T12:00:00+00:00 https://achieverx.com/achieve-announces-20m-svb-loan-refinancing/ 2024-07-30T21:38:46+00:00 https://achieverx.com/achieve-announces-fda-breakthrough-therapy-designation-to-cytisinicline/ 2024-07-31T12:00:00+00:00 https://achieverx.com/achieve-reports-2q24-financial-results/ 2024-08-13T20:01:00+00:00 https://achieverx.com/wp-content/uploads/2024/08/achv-2q24.png https://achieverx.com/achieve-announces-changes-in-executive-leadership-and-board-of-directors/ 2024-08-26T20:30:00+00:00 https://achieverx.com/achieve-apppoints-dr-mark-rubinstein-as-head-of-medical-affairs/ 2024-10-01T12:00:00+00:00 https://achieverx.com/achieve-announces-orca-ol-enrollment-completion-and-sucessful-dsmc-meeting/ 2024-10-10T12:00:00+00:00 https://achieverx.com/achieve-promotes-jaime-xinos-to-chief-commercial-officer/ 2024-10-16T12:00:00+00:00 https://achieverx.com/achieve-president-and-cmo-cindy-jacobs-speaks-at-fda-and-nih-smoking-cessation-public-meeting/ 2024-10-23T12:00:00+00:00 https://achieverx.com/achieve-to-announce-3q24-financial-results/ 2024-10-24T12:00:00+00:00 https://achieverx.com/achieve-reports-3q24-financial-results/ 2024-11-07T21:01:00+00:00 https://achieverx.com/wp-content/uploads/2024/11/achv-3q24.jpg https://achieverx.com/achieve-announces-upcoming-investor-conference-participation-2/ 2024-11-14T13:30:00+00:00 https://achieverx.com/achieve-to-advance-first-vaping-cessation-therapy/ 2024-12-03T13:30:00+00:00 https://achieverx.com/achieve-appoints-mark-oki-as-cfo/ 2024-12-09T13:30:00+00:00 https://achieverx.com/achieve-to-host-meetings-at-jpm-conference/ 2025-01-06T13:30:00+00:00 https://achieverx.com/achieve-announces-critical-orca-ol-milestone-reached/ 2025-01-07T13:30:00+00:00 https://achieverx.com/achieve-appoints-dr-kristen-slaoui-and-nancy-phelan-to-board-of-directors/ 2025-01-10T13:30:00+00:00 https://achieverx.com/achieve-announces-positive-orca-ol-dsmc-review/ 2025-02-10T20:50:55+00:00 https://achieverx.com/achieve-to-present-at-oppenheimer-healthcare-conference/ 2025-02-11T13:30:00+00:00 https://achieverx.com/achieve-to-announce-2024-financial-results/ 2025-03-19T19:43:30+00:00 https://achieverx.com/achieve-announces-jama-publication-of-orca-3-smoking-cessation-trial/ 2025-04-21T21:05:22+00:00 https://achieverx.com/achieve-to-announce-1q25-financial-results/ 2025-05-06T12:30:00+00:00 https://achieverx.com/achieve-reports-1q25-financial-results/ 2025-05-13T11:30:00+00:00 https://achieverx.com/wp-content/uploads/2025/05/achv1q25.jpg https://achieverx.com/achieve-to-present-at-2025-ats-conference/ 2025-05-20T12:30:00+00:00 https://achieverx.com/achieve-to-present-at-jefferies-global-healthcare-conference/ 2025-05-28T12:30:00+00:00 https://achieverx.com/achieve-announces-cytisinicline-nda-submission/ 2025-06-26T20:01:00+00:00 https://achieverx.com/achieve-announces-omnicom-partnership-to-execute-potential-new-nicotine-dependence-treatment-launch/ 2025-06-26T20:02:00+00:00 https://achieverx.com/achieve-announces-proposed-underwritten-public-offering-2/ 2025-06-26T20:03:00+00:00 https://achieverx.com/achieve-announces-pricing-of-45-million-underwritten-public-offering/ 2025-06-27T03:44:26+00:00 https://achieverx.com/achieve-announces-closing-of-45-million-underwritten-public-offering/ 2025-06-30T23:54:11+00:00 https://achieverx.com/achieve-to-announce-2q25-financial-results/ 2025-07-24T12:30:00+00:00 https://achieverx.com/achieve-to-participate-in-btig-virtual-biotechnology-conference/ 2025-07-29T12:30:00+00:00 https://achieverx.com/achieve-announces-2q25-financial-results/ 2025-08-07T11:30:00+00:00 https://achieverx.com/wp-content/uploads/2025/08/achv-2q25-financials.jpg https://achieverx.com/achieve-announces-participation-at-upcoming-investor-conferences-3/ 2025-09-02T12:30:00+00:00 https://achieverx.com/achieve-announces-fda-acceptance-of-cytisinicline-nda/ 2025-09-03T12:30:00+00:00 https://achieverx.com/achieve-names-dr-mark-rubinstein-interim-chief-medical-officer/ 2025-09-11T21:02:30+00:00 https://achieverx.com/achieve-promotes-craig-donnelly-to-chief-operations-officer/ 2025-09-18T12:30:00+00:00 https://achieverx.com/achieve-announces-thorax-publication-of-cytisiniclines-potential-efficacy-and-tollerability-for-smoking-cessation-in-individuals-with-copd/ 2025-09-22T12:30:00+00:00 https://achieverx.com/achieve-announces-grant-of-new-hire-inducement-awards/ 2025-10-02T20:01:00+00:00 https://achieverx.com/achieve-receives-fda-commissioners-national-priority-voucher-for-treatment-of-nicotine-dependence-for-e-cigarette-or-vaping-cessation/ 2025-10-17T11:30:00+00:00 https://achieverx.com/achieve-appoints-erik-atkisson-as-chief-legal-officer/ 2025-10-20T12:30:00+00:00 https://achieverx.com/achieve-to-announce-3q25-financial-results/ 2025-10-29T12:30:00+00:00 https://achieverx.com/achieve-meets-key-milestones-advancing-cytisinicline-nda-for-smoking-cessation/ 2025-11-03T13:30:00+00:00 https://achieverx.com/achieve-announces-3q25-financial-results/ 2025-11-06T12:00:00+00:00 https://achieverx.com/wp-content/uploads/2025/11/achv-3q25.jpg https://achieverx.com/achieve-announced-grant-of-new-hire-inducement-awards/ 2025-12-08T21:01:00+00:00 https://achieverx.com/achieve-to-host-meetings-during-jpmorgan-healthcare-conference-week/ 2025-12-17T21:01:00+00:00 https://achieverx.com/achieve-confirms-promotion-of-dr-mark-rubinstein-to-chief-medical-officer/ 2026-01-12T13:00:00+00:00 https://achieverx.com/achieve-announced-granting-of-new-hire-inducement-awards/ 2026-01-30T21:15:45+00:00 https://achieverx.com/achieve-presents-orca-ol-data-at-srnt/ 2026-03-04T13:00:00+00:00 https://achieverx.com/achieve-to-announce-2025-financial-results/ 2026-03-17T12:30:00+00:00 https://achieverx.com/achieve-reports-2026-financial-results-and-provides-business-update/ 2026-03-24T11:00:00+00:00 https://achieverx.com/wp-content/uploads/2026/03/achv-ye-4q26.png https://achieverx.com/achieve-announces-nicotine-and-tabacco-research-publication/ 2026-03-26T12:30:00+00:00 https://achieverx.com/achieve-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma/ 2026-04-15T12:00:00+00:00 https://achieverx.com/achieve-appoints-andrew-d-goldberg-md-as-ceo-and-to-board-of-directors/ 2026-04-16T13:07:08+00:00 https://achieverx.com/achieve-announces-up-to-354m-private-placement/ 2026-04-16T13:07:22+00:00 https://achieverx.com/achieve-to-announce-1q26-financial-results/ 2026-05-05T18:09:20+00:00 https://achieverx.com/achieve-reports-1q26-financial-results-and-provides-business-update/ 2026-05-12T11:00:00+00:00 https://achieverx.com/wp-content/uploads/2026/05/achv-1q26.png https://achieverx.com/achieve-strengthens-board-and-commercial-leadership-with-three-senior-appointments-from-team-previously-at-verona-pharma/ 2026-05-12T11:05:00+00:00 https://achieverx.com/achieve-presents-safety-data-from-52-weeks-of-continuous-cytisinicline-treatment/ 2026-05-19T18:15:00+00:00 https://achieverx.com/achieve-appoints-jeffrey-farrow-and-reid-waldman-md-to-board-of-directors/ 2026-06-02T12:30:00+00:00 https://achieverx.com/achieve-receives-complete-response-letter-from-fda-for-cytisinicline-nda/ 2026-06-22T12:30:00+00:00 https://achieverx.com/achieve-joins-russell-2000-index/ 2026-06-29T12:30:00+00:00 https://achieverx.com/achieve-announced-granting-of-new-hire-inducement-awards-2/ 2026-07-31T12:30:00+00:00 https://achieverx.com/achieve-appoints-ronald-dadino-and-gloria-cosgrove-to-lead-cmc-supply-chain-and-quality/ 2026-08-03T12:30:00+00:00 https://achieverx.com/achieve-reports-2q26-financial-results-and-provides-business-updates/ 2026-08-11T12:30:00+00:00 https://achieverx.com/wp-content/uploads/2026/08/achv-2q26-1.png https://achieverx.com/achieve-announced-granting-of-new-hire-inducement-awards-3/ 2026-09-03T21:15:00+00:00 https://achieverx.com/achieve-to-present-52-week-cytisinicline-efficacy-data-for-smoking-and-e-cigarette-cessation-at-chest-2026/ 2026-09-28T12:30:00+00:00 https://achieverx.com/achieve-appoints-benjamin-halladay-as-cfo/ 2026-10-01T12:30:00+00:00 https://achieverx.com/achieve-announces-grant-of-new-hire-inducement-awards-2/ 2026-10-06T20:02:00+00:00 https://achieverx.com/achieve-appoints-kaitlyn-tuson-as-svp-marketing-and-communications/ 2026-10-07T12:30:00+00:00 https://achieverx.com/achieve-presents-52-week-cytisinicline-results-for-smoking-and-vaping-cessation-at-chest-2026/ 2026-10-21T12:30:00+00:00 https://achieverx.com/achieve-reports-2024-financial-results/ 2026-10-28T19:53:15+00:00 https://achieverx.com/wp-content/uploads/2025/04/achieve-lifestyle1.jpg https://achieverx.com/achieve-to-present-at-barclays-27th-annual-healthcare-conference/ 2026-10-28T19:53:17+00:00 https://achieverx.com/achieve-appoints-dr-vaughn-himes-to-board-of-directors/ 2026-10-28T19:53:18+00:00 https://achieverx.com/achieve-reports-2q23-financial-results/ 2026-10-28T19:53:18+00:00 https://achieverx.com/wp-content/uploads/2023/08/ACHV-2Q23.jpg https://achieverx.com/achieve-announces-expansion-of-cytisinicline-clinical-operations-team-and-inducement-award-grant/ 2026-10-28T19:53:19+00:00